214 related articles for article (PubMed ID: 28811533)
1. Plasma metabolomics profiling of maintenance hemodialysis based on capillary electrophoresis - time of flight mass spectrometry.
Liu S; Wang L; Hu C; Huang X; Liu H; Xuan Q; Lin X; Peng X; Lu X; Chang M; Xu G
Sci Rep; 2017 Aug; 7(1):8150. PubMed ID: 28811533
[TBL] [Abstract][Full Text] [Related]
2. A computational strategy for metabolic network construction based on the overlapping ratio: Study of patients' metabolic responses to different dialysis patterns.
Huang X; Wang Z; Su B; He X; Liu B; Kang B
Comput Biol Chem; 2021 Aug; 93():107539. PubMed ID: 34246891
[TBL] [Abstract][Full Text] [Related]
3. CE-MS-Based Identification of Uremic Solutes Specific to Hemodialysis Patients.
Akiyama Y; Kikuchi K; Toyohara T; Mishima E; Suzuki C; Suzuki T; Nakayama M; Tomioka Y; Soga T; Abe T
Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33946481
[TBL] [Abstract][Full Text] [Related]
4. Plasma Lipidomics Investigation of Hemodialysis Effects by Using Liquid Chromatography-Mass Spectrometry.
Wang L; Hu C; Liu S; Chang M; Gao P; Wang L; Pan Z; Xu G
J Proteome Res; 2016 Jun; 15(6):1986-94. PubMed ID: 27151145
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
[TBL] [Abstract][Full Text] [Related]
6. Metabolite Profiling of Feces and Serum in Hemodialysis Patients and the Effect of Medicinal Charcoal Tablets.
Liu S; Liang S; Liu H; Chen L; Sun L; Wei M; Jiang H; Wang J
Kidney Blood Press Res; 2018; 43(3):755-767. PubMed ID: 29804117
[TBL] [Abstract][Full Text] [Related]
7. Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.
Zhang ZH; Mao JR; Chen H; Su W; Zhang Y; Zhang L; Chen DQ; Zhao YY; Vaziri ND
Clin Biochem; 2017 Dec; 50(18):1078-1086. PubMed ID: 28928007
[TBL] [Abstract][Full Text] [Related]
8. Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients.
Mutsaers HA; Engelke UF; Wilmer MJ; Wetzels JF; Wevers RA; van den Heuvel LP; Hoenderop JG; Masereeuw R
PLoS One; 2013; 8(8):e71199. PubMed ID: 23936492
[TBL] [Abstract][Full Text] [Related]
9. Metabolic profiling for the identification of Huntington biomarkers by on-line solid-phase extraction capillary electrophoresis mass spectrometry combined with advanced data analysis tools.
Pont L; Benavente F; Jaumot J; Tauler R; Alberch J; Ginés S; Barbosa J; Sanz-Nebot V
Electrophoresis; 2016 Mar; 37(5-6):795-808. PubMed ID: 26685060
[TBL] [Abstract][Full Text] [Related]
10. Capillary Electrophoresis-Mass Spectrometry for Clinical Metabolomics.
Ramautar R
Adv Clin Chem; 2016; 74():1-34. PubMed ID: 27117659
[TBL] [Abstract][Full Text] [Related]
11. Decreases in plasma MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios in uremic patients during hemodialysis.
Lu LC; Yang CW; Hsieh WY; Chuang WH; Lin YC; Lin CS
Clin Exp Nephrol; 2016 Dec; 20(6):934-942. PubMed ID: 26711243
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Profiling with Gas Chromatography-Mass Spectrometry and Capillary Electrophoresis-Mass Spectrometry Reveals the Carbon-Nitrogen Status of Tobacco Leaves Across Different Planting Areas.
Zhao J; Zhao Y; Hu C; Zhao C; Zhang J; Li L; Zeng J; Peng X; Lu X; Xu G
J Proteome Res; 2016 Feb; 15(2):468-76. PubMed ID: 26784525
[TBL] [Abstract][Full Text] [Related]
13. An Enlarged Profile of Uremic Solutes.
Tanaka H; Sirich TL; Plummer NS; Weaver DS; Meyer TW
PLoS One; 2015; 10(8):e0135657. PubMed ID: 26317986
[TBL] [Abstract][Full Text] [Related]
14. Reliability of plasma polar metabolite concentrations in a large-scale cohort study using capillary electrophoresis-mass spectrometry.
Harada S; Hirayama A; Chan Q; Kurihara A; Fukai K; Iida M; Kato S; Sugiyama D; Kuwabara K; Takeuchi A; Akiyama M; Okamura T; Ebbels TMD; Elliott P; Tomita M; Sato A; Suzuki C; Sugimoto M; Soga T; Takebayashi T
PLoS One; 2018; 13(1):e0191230. PubMed ID: 29346414
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Exploring blood alterations in chronic kidney disease and haemodialysis using metabolomics.
Gagnebin Y; Jaques DA; Rudaz S; de Seigneux S; Boccard J; Ponte B
Sci Rep; 2020 Nov; 10(1):19502. PubMed ID: 33177589
[TBL] [Abstract][Full Text] [Related]
17. Combination of maintenance hemodialysis with hemoperfusion: a safe and effective model of artificial kidney.
Chen SJ; Jiang GR; Shan JP; Lu W; Huang HD; Ji G; Wu P; Wu GF; Wang W; Zhu C; Bian F
Int J Artif Organs; 2011 Apr; 34(4):339-47. PubMed ID: 21534244
[TBL] [Abstract][Full Text] [Related]
18. Effect of blood purification on serum miR-126 and VEGF levels in the process of atherosclerosis in uremic patients under maintenance hemodialysis.
Zhao D; Shao H
Kaohsiung J Med Sci; 2018 Aug; 34(8):447-455. PubMed ID: 30041762
[TBL] [Abstract][Full Text] [Related]
19. Metabolite profiling of hemodialysate using gas chromatography time-of-flight mass spectrometry.
Qi X; Zhang Y; Gao J; Chen T; Zhao A; Yan Y; Jia W
J Pharm Biomed Anal; 2011 Jul; 55(5):1142-7. PubMed ID: 21530126
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
